Atlas Trials

Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)

Clinical trial NCT01953536 · WITHDRAWN

Trial details

NCT number
NCT01953536
Sponsor
Endocyte
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2014-04-01
Primary completion
2016-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.